Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.66 USD
Change Today -0.0173 / -2.57%
Volume 855.7K
RXII On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
NASDAQ CM
Frankfurt
As of 8:10 PM 05/5/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Tod M. Woolf Ph.D.

AgeTotal Calculated CompensationThis person is connected to 20 board members in 2 different organizations across 7 different industries.

See Board Relationships
49--

Background*

Dr. Tod M. Woolf, Ph.D serves as the Chief Business Officer at X-BODY, Inc. Dr. Woolf was Founder of RXi Pharmaceuticals Corporation and served as its Chief Executive Officer and President since January 2007. He has 20 years of experience developing and commercializing innovative biomedical technologies, and is a recognized leader in RNA therapeutics. He was Founder of Galena Biopharma, Inc. and served as its President and Chief Executive Officer from February 22, 2007 ...

Read Full Background

Corporate Headquarters*

257 Simarano Drive
Marlborough, Massachusetts 01752

United States

Phone: 508-767-3861
Fax: 508-767-3862

Board Members Memberships*

2007-2009
Former Member of Scientific Advisory Board

Education*

Doctorate 1991
Harvard University
Master's Degree 1991
Harvard University
BS
University of Michigan

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RXII:US $0.66 USD -0.0173

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RXI PHARMACEUTICALS, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.